凱萊英 (6821.HK)

60.000 -4.400 (-6.83%) 收市：04:08PM HKT

凱萊英

No. 6 Dongting 3rd Street
Economic-Technological Development Area
Tianjin
China

https://www.asymchem.com.cn

版塊: Healthcare
行業: Biotechnology
全職員工: 9,788

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Hao Hong Ph.D.	Founder, Chairman & CEO	10.06M	無	1956
Ms. Rui Yang	Co-CEO & Executive Director	7.3M	無	1978
Mr. Da Zhang	CFO, Senior VP & Executive Director	6.34M	無	1981
Dr. Liang Hong	Executive VP & Executive Director	3.89M	無	1974
Dr. Xinhui Hu Ph.D.	CTO & CBO	無	無	1975
Dr. James Randolph Gage Ph.D.	Chief Scientific Officer	無	無	1964
Mr. Chaoyong Chen	Executive Vice President	無	無	1981
Ms. Elut Hsu	Senior Vice President of Business Development	無	無	無
Dr. Pingzhong Huang Ph.D.	Senior Vice President of Process Development	無	無	無
Mr. Changhai Tian	Senior Vice President of 5S Management	無	無	無

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; information technology services; and pharmaceutical science and technology development activities, as well as sale, wholesale, and retail of drugs. In addition, it is involved in the manufacture, development, and sale of medicine raw materials and relevant products; manufacture of chemical products; and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.

公司管治

截至 無 止，凱萊英 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。